Swedish Pharmaceuticals & Biotech Nano Cap Stocks

Cantargia

Market Cap: SEK 439.5m

A biotechnology company, develops pharmaceuticals for treatment of cancer, inflammatory, and autoimmune diseases.

Sprint Bioscience

Market Cap: SEK 382.0m

A pharmaceutical company, engages in the development of drug candidates to treat cancer in Sweden.

Elicera Therapeutics

Market Cap: SEK 155.5m

A clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden.

Subgen AI

Market Cap: SEK 89.2m

Develops artificial intelligence-based models and applications to control data for government and businesses.

Ascelia Pharma

Market Cap: SEK 71.4m

A biotech company, develops identifies, develops, and commercializes novel drugs to treat orphan oncology treatments in Sweden.

Pila Pharma

Market Cap: SEK 54.1m

Operates as a clinical stage biotech company in Sweden.

ODI Pharma

Market Cap: SEK 42.5m

A pharmaceutical company, engages in the production and distribution of pharmaceutical cannabis and cosmetics products in Europe.

Chosa Oncology

Market Cap: SEK 34.4m

Develops oncology drugs cisplatin for the treatment of cancer.

Double Bond Pharmaceutical International

Market Cap: SEK 12.9m

A pharmaceutical company, engages in the development and commercialization of approaches for the treatment of oncological and infectious diseases.